AMPE:Ampio Pharmaceuticals Inc Snapshot | Charting | News | Options
$0.32 OTC Markets Group Inc - Current Information 2:34p ET
April 3 '24 		Ampio Pharmaceuticals Received Audit Opinion with Going Concern Explanation PR Newswire
Last  Change Exchange
Market data is delayed by at least 15 minutes.
Markets Portfolio
    Symbol Lookup
    Latest Story Top Stories on AMPE
    No News Available
    Ampio Announces Voluntary Delisting and SEC Deregistration
    5:00p ET March 25 '24 PR Newswire
    Ampio Provides Update on Results from Pre-IND Enabling Studies
    5:45p ET February 14 '24 PR Newswire

    Market data provided by News provided by


    This site is published in the United States for U.S. residents only. The services offered within this site are available exclusively through our U.S. Financial Advisors. Stifel Nicolaus Financial Advisors may only conduct business with residents of the state in which they are properly registered. The information on this website is not an offer to sell or a solicitation of an offer to buy, any security, nor shall any such security be offered or sold to any person in any jurisdiction in which such offer, solicitation, purchase or sale may not lawfully be made.
    Important Disclosures | Privacy Notice | HIPAA Policy | Use of Information Policy | Business Continuity | Canada Trade Matching Statement

    Stifel, Nicolaus & Co., Inc. Member NYSE, FINRA, and SIPC.
    Stifel Nicolaus Canada Inc., is a member of CIPF/FCPE and IIROC
    Copyright © 2024 All rights reserved.